Scientist-Recipients Treasure Freedom As MacArthur Fellowships' Biggest Asset

When the Chicago-based John D. and Catherine T. MacArthur Foundation announced the names of the 36 new MacArthur Fellows this past summer, there were eight scientists included on the list. But according to Kenneth Hope, director of the MacArthur Fellows Program, it makes no difference to foundation officials whether this year's recipients are physicists, painters, or poets. "We never make distinctions by field," Hope says. Rather, "individuals who show creativity and promise and who have the po

Written byLisa Simon
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Fellowship awards range from $150,000 to $375,000, over five years, plus health insurance. Specific fellowship amounts are determined by the recipient's age, from 21 up to 60. For instance, a 21-year-old MacArthur fellow receives $30,000 a year. The amount increases by $1,000 a year up to age 60. And each year within the five-year span of the fellowship, the amount given per year also increases by $1,000. Fellowships are unrestricted, with no reporting requirements.

One cannot apply for a Mac-Arthur fellowship; one must be nominated. Nominations are made by a committee of more than 100 members who serve anonymously for one year. They never meet as a group; rather, they review information and pass it on to Fellows Program administrators. All nominations are reviewed by a 13-member selection committee, with final approval given by the foundation's board.

Besides the fellowships, the MacArthur Foundation funds a Health Program, which focuses on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies